Skip to content

Study on the construction of standardized flow of respiratory support centered on high flow oxygen therapy in patients with chronic obstructive pulmonary disease complicated with respiratory failure

Study on the construction of standardized flow of respiratory support centered on high flow oxygen therapy in patients with chronic obstructive pulmonary disease complicated with respiratory failure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040437
Enrollment
Unknown
Registered
2020-11-28
Start date
2021-07-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

NCO:NCO
NIV:NIV

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. Patients diagnosed with COPD and combined with type II respiratory failure and undergoing invasive ventilation; bronchial-pulmonary infections aggravate COPD combined with respiratory failure; PIC window appears after invasive ventilation and anti-infection treatment (item 1); 3. Diagnosed as AECOPD; and arterial blood gas PH 7.25-7.35, PaCO2> 50 mmHg (item 2); 4. Diagnosed as AECOPD, and arterial blood gas PH 7.20-7.24, PaCO2> 50 mmHg (item 3).

Exclusion criteria

Exclusion criteria: 1. Those who need emergency tracheal intubation; 2. Unable to obtain informed consent; 3. Those who have NIV contraindications: oral and facial trauma, poor sputum excretion ability, unstable hemodynamics, etc.; 4. Those with a poor short-term prognosis and those with a high risk of death within 7 days are undergoing palliative treatment; 5. Severe heart, brain, liver, and kidney organ failure; 6. When the PIC window appears, the cough reflex is extremely weak or the expectoration is weak (item 1); 7. Those with pneumothorax, hemoptysis, and severe pneumonia; 8. Those who cannot obtain informed consent.

Design outcomes

Secondary

MeasureTime frame
Comfort score;Dyspnea score;Changes of diaphragm function;Length of stay;28 day mortality;

Primary

MeasureTime frame
Arterial blood gas;Respiratory rate;heart rate;blood pressure;

Countries

China

Contacts

Public ContactDingyu Tan

Northern Jiangsu People's Hospital

32494845@qq.com+86 18051061672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026